© 1989

Drug Resistance in Cancer Therapy

  • Robert F. Ozols

Part of the Cancer Treatment and Research book series (CTAR, volume 48)

Table of contents

  1. Front Matter
    Pages i-xiii
  2. Robert C. Young
    Pages 1-12
  3. Antonio T. Fojo
    Pages 27-36
  4. James H. Gerlach
    Pages 37-53
  5. Alok Bhushan, John C. Kermode, James Posada, Thomas R. Tritton
    Pages 55-72
  6. Douglas E. Merkel, Suzanne A. W. Fuqua, William L. McGuire
    Pages 97-105
  7. Robert L. Fine, Marti Jett, Jitendra Patel, James Carmichael, Change-Ho Ahn
    Pages 107-123
  8. Margie L. Clapper, Kenneth D. Tew
    Pages 125-150
  9. Thomas C. Hamilton, Gi-Ming Lai, Mace L. Rothenberg, Antonio T. Fojo, Robert C. Young, Robert F. Ozols
    Pages 151-169
  10. Lorraine A. Cazenave, Jeffrey A. Moscow, Charles E. Myers, Kenneth H. Cowan
    Pages 171-187
  11. James B. Mitchell, Angelo Russo, John A. Cook, Eli Glatstein
    Pages 189-203
  12. Back Matter
    Pages 205-210

About this book


Where do you begin to look for a recent, authoritative article on the diagnosis or management of a particular malignancy? The few general oncology textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals frequently publish good in-depth reviews of cancer topics, and published symposium lectures are often the best overviews available. Unfor­ tunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes that aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion: first, by dividing the oncology literature into specific subdivisions such as lung can­ cer, genitourinary cancer, and pediatric oncology; second, by asking emi­ nent authorities in each of these areas to edit a volume on the specific topic on an annual or biannual basis. Each topic and tumor type is covered in a volume appearing frequently and predictably, discussing current diagnosis, staging, markers, all forms of treatment modalities, basic biology, and more.


Staging Tumor breast cancer calcium cancer cancer therapy cancer treatment cell chemotherapy diagnosis drug drug resistance radiation research resistance

Editors and affiliations

  • Robert F. Ozols
    • 1
  1. 1.Fox Chase Cancer CenterPhiladelphiaUSA

Bibliographic information

  • Book Title Drug Resistance in Cancer Therapy
  • Editors Robert F. Ozols
  • Series Title Cancer Treatment and Research
  • DOI
  • Copyright Information Springer-Verlag US 1989
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Hardcover ISBN 978-0-7923-0244-5
  • Softcover ISBN 978-1-4612-8886-2
  • eBook ISBN 978-1-4613-1601-5
  • Series ISSN 0927-3042
  • Edition Number 1
  • Number of Pages XIV, 210
  • Number of Illustrations 0 b/w illustrations, 0 illustrations in colour
  • Topics Oncology
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Oncology & Hematology


`This book would be a helpful text for basic researchers, clinical investigators, and medical housestaff. It is well written and can be read in a relatively short period.'
Breast Cancer Research and Treatment, 19, 1991
` The book is an exciting survey of the potential application of laboratory data. It is a good example of interdisciplinary research collaboration. It is recommended reading for those engaged in the development of new treatment strategies.'
Oncology, 48/1